Aug 19, 2020 / NTS GMT
Operator
And welcome to the VolitionRx webinar. It is now my pleasure to introduce your host, Scott Powell, Head of Investor Relations and US Chief Financial Officer. Thank you, Mr. Powell, you may begin.
Scott Powell - VolitionRx Ltd. - EVP, IR & CFO, Volition America,Inc.
Thank you and welcome everyone to the VolitionRx presentation. Appreciate all of you joining virtually and hopefully all of you can see the Volition slide deck.
I do want to point you to our forward-looking statements. So, I'll be making some forward-looking statements on this virtual presentation and to point to the Safe Harbor Act.
And some highlights here about Volition. We are a diagnostics company. We're developing blood tests primarily to screen for a variety of different cancers. But for those of you who have been following our recent news flow, you'll see that we are also developing a blood test for our first noncancer indication for the coronavirus. And I'll start with that since that particular disease is on most of our minds these days.
So, I'll move to slide 3.
VolitionRX Ltd At SNN Network Transcript
Aug 19, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers